Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB26FAZBD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,642
Award facts
- Contract value 100% obligated
- $4,642.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The award was issued on October 22, 2025, with an ultimate completion date of November 13, 2025, under a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group will perform this work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a $499.99 billion ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. As a prime vendor under this initiative, DMS Pharmaceutical Group supplies an extensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to support military medical operations globally, with demonstrated performance across numerous prior delivery orders issued by the DLA Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DB26FAZBD?
SPE2DB26FAZBD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FAZBD worth?
The government has obligated $4,642 on SPE2DB26FAZBD.
Is contract SPE2DB26FAZBD an order under another contract?
Yes. SPE2DB26FAZBD is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB26FAZBD competed?
The extent of competition for SPE2DB26FAZBD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award